Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-44.73	23.97	43.36
Graham Fair Price	28.46	39843.67	31015.52
PEG	-80.02	-0.03	0.13
Price/Book	0.02	0.54	0.54
Price/Cash Flow	256.70	60.39	16.93
Prices/Earnings	-38.65	6.67	-10.86
Price/Sales	-2.99	1.53	1.58
Price/FCF	256.70	60.39	16.93
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	39.18	0.16	0.11
Operating Margin	1326.45	0.06	< 0.005
ROA	63.59	0.01	< 0.005
ROE	-0.01	0.02	63.03
ROIC	< 0.005	0.01	764.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.02	-42.08
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.89	13.75	1448.88
EPS QOQ	0.86	2.64	207.02
FCF QOQ	6.39	-0.72	-88.76
Revenue QOQ	-0.08	0.03	-57.99
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	41.81	46.32	10.78
Days Sales Outstanding (DSO)	64.98	67.61	4.04
Inventory Turnover	2.15	1.94	-9.73
Debt/Capitalization	0.40	0.39	-1.66
Quick Ratio	0.95	0.94	-1.46
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	58426.61	58784.08	0.61
Cash	7205.81	6600.51	-8.40
Capex	-379.31	-479.34	-26.37
Free Cash Flow	1878.37	529.90	-71.79
Revenue	20151.37	20903.70	3.73
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.32	1.33	0.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.62	11.87	-45.10
Naive Interpretation	Member

06 - Financial Health · Weak

Rating